Table 1 Description of baseline characteristics for the study participants
Characteristics | Total participants (n = 6685) |
|---|---|
Age (years), mean (SD) | 59.7 (7.0) |
Sex (female), n (%) | 542 (8.1) |
White ethnicity, n (%) | 6354 (95.4) |
With college or university degree, n (%) | 676 (10.2) |
BMI (kg/m 2 ), mean (SD) | 30.6 (4.9) |
BMI Categories, n (%) | |
Underweight (< 18.5 kg/m2) | 1 (0.0) |
Normal weight (18.5–24.9 kg/m2) | 577 (8.7) |
Overweight (25.0 to 29.9 kg/m2) | 2846 (42.8) |
Obese (≥ 30.0 kg/m2) | 3230 (48.5) |
MH status, n (%) | 572 (8.6) |
Smoking status, n (%) | |
Never | 2821 (42.4) |
Previous | 3214 (48.3) |
Current | 622 (9.3) |
Alcohol intake status, n (%) | |
Never | 127 (1.9) |
Previous | 235 (3.5) |
Current | 6308 (94.6) |
Physical activity (≥ 600 MET min per week), n (%) | 4261 (77.1) |
Diabetes, n (%) | 845 (12.6) |
Hypertension, n (%) | 3823 (57.2) |
High cholesterol, n (%) | 2067 (30.9) |
Osteoarthritis, n (%) | 1131 (16.9) |
Rheumatoid arthritis, n (%) | 113 (1.7) |
CKD, n (%) | 127 (1.9) |
NSAIDs, n (%) | 1529 (22.9) |
Antihypertensive drugs, n (%) | 3,303 (49.4) |
Antidiabetic medications, n (%) | 615 (9.2) |
Statins, n (%) | 2517 (37.7) |
Vitamins, n (%) | 1696 (25.6) |
Minerals and other dietary supplementation, n (%) | 2656 (39.8) |
Urate–lowering drugs | 4422 (66.1) |
Serum urate (umol/L), mean (SD) | 379.4 (103.4) |
HbA1c (%), mean (SD) | 5.6 (0.8) |